SOLACI PERIPHERAL | 2nd Clinical Case: Juxtarenal Abdominal Aortic Aneurysm

Discusión de caso clínico

SOLACI’s Department of Peripheral Endovascular Interventions brings a new challenging clinical case for the whole Latin American medical community so as to continue fostering and sharing scientific knowledge and experience among peers.

Tell us what you think about this case and its resolution using the comments section in this post, and answer the questions featured in the last part of this article.


Juxtarenal Abdominal Aortic Aneurysm


Authors: Dr. Luis R. Virgen Carrillo, MD, PhD / Dr. Carlos Salazar, MD / Dr. Rodolfo Siordia Zamorano, MD.

E-mail: drvirgen@cardiovascular.mx; Twitter: @drluisvirgen

Institution: Virgen Cardiovascular Research, Guadalajara, Mexico, & Cirujanos Cardiovasculares del Noroeste.


– Male patient, 61 years old, anesthesiologist, cigarette smoker, hypertensive. He begins experiencing intense abdominal pain. Hb reduction, 14-11 g/dL. He is hemodynamically stable; blood pressure 110/60 mmHg, heart rate 68 bpm. An abdominal computed tomography angiography shows the contained rupture of an abdominal aneurysm. Anatomy: juxtarenal aneurysm without neck, with small, tortuous iliac arteries.

Caso SOLACI PERIPHERAL - Aneurisma de Aorta Abdominal Yuxtarrenal


Case Resolution

– The algorithm for the attention of patients with suspected abdominal aneurysm rupture is activated. Physicians choose a percutaneous endovascular treatment (the chimney technique [chEVAR]).

Caso Clínico SOLACI Peripheral

– The procedure is conducted in a hybrid cath lab; bilateral femoral artery puncture, guided by ultrasound and image fusion. Two Perclose devices are used in each femoral artery. Both brachial arteries are dissected; an 8-Fr flexor introducer sheath is placed inside each renal artery. Selective renal artery catheterization and stenting using an 8×39 film-coated BeGraft (Bentley Innomed GmbH, Hechingen, Germany). A parallel 0.035” Magic Torque guidewire ×260 cm is used. Then, an Ovation 26 Abdominal Stent Graft System (Endologix, California, USA), 14-15 Fr OD, is used. The device is placed using image fusion, the fill polymer is delivered, and both BeGraft stents are implanted. After the procedure, there is a type Ia endoleak in peri-chimney spaces (“gutters”). New dilation conducted with partial improvement. A decision is made to conduct an embolization with an Onix device at a second instance.

– The patient is stable and does not experience pain. An ultrasound is conducted within 24 hours: no flow in the aneurysm sac.

2° Caso SOLACI Peripheral Aneurisma de aorta abdominal yuxtarrenal

– A computed tomography angiography is conducted at 72 hours, 1, 6, and 12 months; no endoleaks. (VIDEO #2)


Questions

  1. Is there an algorithm for the attention of patients with suspected abdominal aneurysm rupture at your site?
  2. In your opinion, what is the best option for a patient with aneurysm rupture: surgical treatment or endovascular treatment?
  3. What is your treatment of choice for para/juxtarenal aneurysms?
  4. Should type I endoleaks be treated in the cath lab?

Join the conversation through the comments in this post!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...